Results Of Secondary Implantation By Sutureless Scleral Fixation Carlevale Intra Ocular Lens: A Prospective Study Of 15 Cases.
Published 2023 - 41st Congress of the ESCRS
Reference: PP13.12 | Type: Free paper | DOI: 10.82333/prg6-0n15
Authors: Omar BENGEBARA* 1 , IDRISS BENATIYA ANDALOUSSI 2 , Meriem ABDELLAOUI 2 , Fouad CHRAIBI 2 , Ahmed BENNIS 2 , Malek SLIM 3
1OPHTHALMOLOGY,HASSAN II UNIVERSITARY HOSPITAL,FEZ,Morocco;OPHTHALMOLOGY,JACQUES COEUR HOSPITAL,BOURGES,France, 2OPHTHALMOLOGY,HASSAN II UNIVERSITARY HOSPITAL,FEZ,Morocco, 3OPHTHALMOLOGY,JACQUES COEUR HOSPITAL,BOURGES,France
Purpose
Setting
Ophthalmology department Jacques Coeur Hospital, Bourges, France.
Methods
Results
The mean age of our patients was 76 years. The surgical indication was aphakia in 60% of cases, an IOL subluxation in 33% of the cases, and an IOL dislocation in the vitreous cavity in 6%. The mean BCVA was 0.7 ± 0.25 logMAR preoperatively and 0.15 ± 0.33 logMAR. As for the refractive results, the average preoperative SE was +5.34 Dpt ±4.93 and -0.68 Dpt ±0.93 at one year. The mean IOP went from 14.5 to 15.25mmHg and the mean ECD decreased from 1,928 to 1,683 at the end of the follow-up
We assessed one case of intravitreal hemorrhage, two cases of postoperative cystoid macular edema, and one case of haptic exposure.
No cases of reverse pupillary block, ocular hypotonia, subluxation or dislocation of the implant, or endophthalmitis were noted.
Conclusions
Secondary implantation by sutureless scleral fixation Carlevale IOL represents an attractive, reproducible, and minimally invasive surgical technique with very satisfying functional results.
By guaranteeing optimal refractive results and a low complication rate, this IOL has earned its place in the therapeutic arsenal to improve the prognosis of patients with insufficient capsular support.